Umar Maharoof
Janssen Pharmaceutica
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Umar Maharoof.
Bioorganic & Medicinal Chemistry Letters | 2017
David A. Kummer; Maxwell D. Cummings; Marta Cristina Abad; Joseph Kent Barbay; Glenda Castro; Ronald L. Wolin; Kevin D. Kreutter; Umar Maharoof; Cynthia M. Milligan; Rachel Nishimura; Joan Pierce; Celine Schalk-Hihi; John Spurlino; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Craig R. Woods; Xiaohua Xue; James P. Edwards; Anne Fourie; Kristi A. Leonard
A high-throughput screen of the ligand binding domain of the nuclear receptor retinoic acid-related orphan receptor gamma t (RORγt) employing a thermal shift assay yielded a quinoline tertiary alcohol hit. Optimization of the 2-, 3- and 4-positions of the quinoline core using structure-activity relationships and structure-based drug design methods led to the discovery of a series of modulators with improved RORγt inhibitory potency and inverse agonism properties.
Bioorganic & Medicinal Chemistry Letters | 2017
J. Kent Barbay; Maxwell D. Cummings; Marta Cristina Abad; Glenda Castro; Kevin D. Kreutter; David A. Kummer; Umar Maharoof; Cynthia M. Milligan; Rachel Nishimura; Joan Pierce; Celine Schalk-Hihi; John Spurlino; Virginia M. Tanis; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Craig R. Woods; Ronald L. Wolin; Xiaohua Xue; James P. Edwards; Anne Fourie; Kristi A. Leonard
We identified 6-substituted quinolines as modulators of the retinoic acid receptor-related orphan receptor gamma t (RORγt). The synthesis of this class of RORγt modulators is reported, and optimization of the substituents at the quinoline 6-position that produced compounds with high affinity for the receptor is detailed. This effort identified molecules that act as potent, full inverse agonists in a RORγt-driven cell-based reporter assay. The X-ray crystal structures of two full inverse agonists from this chemical series bound to the RORγt ligand binding domain are disclosed, and we highlight the interaction of a hydrogen-bond acceptor on the 6-position substituent of the inverse agonist with Glu379:NH as a conserved binding contact.
Journal of Medicinal Chemistry | 2005
Chih Y. Ho; Donald William Ludovici; Umar Maharoof; Jay Mei; Jan L. Sechler; Robert W. Tuman; Eric Strobel; Laura Andraka; Hwa-Kwo Yen; Gregory C. Leo; Jian Li; Harold R. Almond; Hong Lu; Ann Devine; Rose Tominovich; Judith Baker; Stuart Emanuel; Robert H. Gruninger; Steven A. Middleton; Dana L. Johnson; Robert A. Galemmo
Archive | 2009
Ellen W. Baxter; Allen B. Reitz; Umar Maharoof; Yifang Huang; Christopher John Creighton; Charles H. Reynolds; Chi Luo; Brett A. Tounge; Tina Morgan Ross; Tianbao Lu
Archive | 2003
Chih Yung Ho; Bengt Anders Brunmark; Stuart Emanuel; Jr. Robert A. Galemmo; Dana L. Johnson; Donald William Ludovici; Umar Maharoof; Jay M. Mei; Jan L. Sechler; Eric Strobel; Robert W. Tuman; Hwa Kwo Yen
Archive | 2007
Chih Yung Ho; Bengt Anders Brunmark; Stuart L. Emanuel; Robert A. Galemmo; Dana L. Johnson; Donald William Ludovici; Umar Maharoof; Jay M. Mei; Jan L. Sechler; Eric D. Strobel; Robert W. Tuman; Hwa Kwo Yen
Archive | 2013
Kristi A. Leonard; Kent Barbay; James P. Edwards; Kevin D. Kreutter; David A. Kummer; Umar Maharoof; Rachel Nishimura; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Ronald L. Wolin; Craig R. Woods; Anne Fourie; Xiaohua Xue; Maxwell D. Cummings
Archive | 2011
Paul F. Jackson; Brett A. Tounge; Kristi Leonard; Yan Zhang; Aihua Wang; Michael Hawkins; Umar Maharoof; Joseph Kent Barbay
Archive | 2008
Chih Yung Ho; Yan Zhang; Umar Maharoof; Jeremy Major; John Harrison
Archive | 2013
Kristi A. Leonard; Kent Barbay; James P. Edwards; Kevin D. Kreutter; David A. Kummer; Umar Maharoof; Rachel Nishimura; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Ronald L. Wolin; Craig R. Woods; Anne Fourie; Xiaohua Xue; Maxwell D. Cummings; William M. Jones; Steven Goldberg